1500009L16Rik Activators
1500009L16Rik Activators encompass a range of chemical compounds that indirectly stimulate the functional activity of 1500009L16Rik through distinct signaling pathways. Compounds such as Forskolin and IBMX enhance 1500009L16Rik by increasing intracellular cAMP levels, with Forskolin activating adenylate cyclase and IBMX inhibiting phosphodiesterases, thus augmenting PKA-mediated phosphorylation processes that 1500009L16Rik is associated with. Similarly, Epigallocatechin gallate and Genistein exert their effects by inhibiting kinases that may negatively influence 1500009L16Rik, lifting these inhibitory effects and enabling enhanced activity. PMA, acting as a PKC activator, and Sphingosine-1-phosphate, through receptor-mediated signaling, can both facilitate the activation of 1500009L16Rik by promoting the cellular pathways that it participates in, such as proliferation and survival.
1500009L16Rik activators are chemical entities that enhance the protein's function through a variety of cellular signaling pathways. Forskolin and IBMX, for instance, elevate intracellular cAMP, which in turn activates PKA. This cascade can phosphorylate and thus enhance the activity of 1500009L16Rik in its associated cellular roles. On a different front, Epigallocatechin gallate and Genistein work by inhibiting kinases that otherwise negatively regulate 1500009L16Rik, thereby allowing for an enhanced function of the protein. PMA stimulates PKC, which influences pathways involving 1500009L16Rik, potentially enhancing its role in cell signaling. Additionally, Sphingosine-1-phosphate activates signaling cascades that could potentiate 1500009L16Rik's involvement in cellular processes like proliferation and survival, emphasizing the multifaceted nature of these chemical activators.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, enzymes that break down cAMP. By preventing cAMP degradation, IBMX indirectly increases cAMP levels, which can enhance the activity of 1500009L16Rik through PKA activation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate is a kinase inhibitor that may inhibit kinases which negatively regulate 1500009L16Rik, thus enhancing its activity by reducing inhibitory phosphorylation events. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which can phosphorylate substrates involved in pathways where 1500009L16Rik acts, therefore enhancing its functional role in these pathways. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate acts on its receptors to activate intracellular signaling cascades that can upregulate or potentiate the role of 1500009L16Rik in cellular processes such as proliferation and survival. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can shift the balance of intracellular pathways to enhance the functional activity of 1500009L16Rik by reducing competitive signaling that may inhibit its function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor which modulates the MAPK/ERK pathway, potentially enhancing the activity of 1500009L16Rik by alleviating negative feedback regulation or by rerouting signaling through pathways where 1500009L16Rik is active. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis by inhibiting the SERCA pump, potentially leading to an increase in cytosolic calcium levels, which can activate calcium-dependent signaling pathways and enhance the functional activity of 1500009L16Rik. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore which increases intracellular calcium levels, thereby activating calcium-dependent pathways that could enhance the activity of 1500009L16Rik. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum protein kinase inhibitor that might lead to the selective activation of pathways involving 1500009L16Rik by reducing the phosphorylation of proteins that negatively regulate it. | ||||||